Related Experiment Video
Updated: Oct 18, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
VAV Proteins as Double Agents in Cancer: Oncogenes with Tumor Suppressor Roles
Myriam Cuadrado1,2, Javier Robles-Valero1,2
1Centro de Investigación del Cáncer, CSIC-University of Salamanca, 37007 Salamanca, Spain.
Abstract:
Guanosine nucleotide exchange factors (GEFs) are responsible for catalyzing the transition of small GTPases from the inactive (GDP-bound) to the active (GTP-bound) states. RHO GEFs, including VAV proteins, play essential signaling roles in a wide variety of fundamental cellular processes and in human diseases. Although the most widespread archetype in the field is that RHO GEFs exert proactive functions in cancer, recent studies in mice and humans are providing new insights into the in vivo function of these proteins in cancer. These results suggest a more complex scenario where the role of GEFs is not so clearly defined. For example, VAV1 can unexpectedly play non-catalytic tumor suppressor functions in T-cell acute lymphoblastic leukemia (T-ALL) by controlling the levels of the active form of NOTCH1 (ICN1). This review focuses on emerging work unveiling tumor suppressor roles for these proteins that should prompt a reevaluation of the role of VAV GEF family in tumor biology.
Insights
Guanosine nucleotide exchange factors (GEFs), particularly VAV proteins, may act as tumor suppressors, challenging their traditional cancer-promoting roles. Emerging research reveals complex functions in cancer biology, necessitating a reevaluation of VAV GEF family roles.
Area of Science:
- Molecular Biology
- Cell Signaling
- Oncology
Background:
- Guanosine nucleotide exchange factors (GEFs) activate small GTPases, crucial for cellular processes.
- RHO GEFs, including VAV proteins, are implicated in various cellular functions and diseases.
- Traditionally, RHO GEFs are viewed as promoting cancer progression.
Purpose of the Study:
- To review emerging evidence on the in vivo functions of RHO GEFs in cancer.
- To highlight the potential tumor suppressor roles of VAV proteins.
- To prompt a reevaluation of the VAV GEF family's role in tumor biology.
Main Methods:
- Literature review of recent studies in mice and humans.
- Analysis of VAV1's non-catalytic function in T-cell acute lymphoblastic leukemia (T-ALL).
- Examination of VAV1's role in regulating NOTCH1 signaling.
Main Results:
- Recent studies reveal complex, context-dependent roles for GEFs in cancer.
- VAV1 demonstrates non-catalytic tumor suppressor functions in T-ALL.
- VAV1 regulates the active form of NOTCH1 (ICN1), impacting leukemia development.
Conclusions:
- The role of GEFs in cancer is more nuanced than previously understood.
- VAV proteins can exhibit tumor suppressor activities, contrary to established paradigms.
- Further investigation into VAV GEF family functions is crucial for understanding cancer biology.
More Related Videos
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation
Mechanisms of Retrovirus-induced Cancers